IDEAS home Printed from https://ideas.repec.org/f/ppi532.html
   My authors  Follow this author

Jamison Pike

Personal Details

First Name:Jamison
Middle Name:
Last Name:Pike
Suffix:
RePEc Short-ID:ppi532

Affiliation

Centers for Disease Control and Prevention (Centers for Disease Control and Prevention)

https://www.cdc.gov
Atlanta, GA USA

Research output

as
Jump to: Articles

Articles

  1. Jamison Pike & Andrew J. Leidner & Harrell Chesson & Charles Stoecker & Scott D. Grosse, 2022. "Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines," Applied Health Economics and Health Policy, Springer, vol. 20(4), pages 457-465, July.
  2. Scott D. Grosse & Jamison Pike & Rieza Soelaeman & J. Mick Tilford, 2019. "Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time," PharmacoEconomics, Springer, vol. 37(4), pages 461-473, April.
  3. Jamison Pike & Scott D. Grosse, 2018. "Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review," Applied Health Economics and Health Policy, Springer, vol. 16(6), pages 765-778, December.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Articles

  1. Scott D. Grosse & Jamison Pike & Rieza Soelaeman & J. Mick Tilford, 2019. "Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time," PharmacoEconomics, Springer, vol. 37(4), pages 461-473, April.

    Cited by:

    1. María J. Mendoza-Jiménez & Job Exel & Werner Brouwer, 2024. "On spillovers in economic evaluations: definition, mapping review and research agenda," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(7), pages 1239-1260, September.
    2. Urwin, Sean & Lau, Yiu-Shing & Grande, Gunn & Sutton, Matthew, 2023. "Informal caregiving and the allocation of time: implications for opportunity costs and measurement," Social Science & Medicine, Elsevier, vol. 334(C).
    3. Gold, Heather T. & McDermott, Cara & Hoomans, Ties & Wagner, Todd H., 2022. "Cost data in implementation science: categories and approaches to costing," LSE Research Online Documents on Economics 113704, London School of Economics and Political Science, LSE Library.
    4. Eve Wittenberg & Lyndon P. James & Lisa A. Prosser, 2019. "Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature," PharmacoEconomics, Springer, vol. 37(4), pages 475-499, April.
    5. Henry, Edward & Cullinan, John, 2021. "Mental health spillovers from serious family illness: Doubly robust estimation using EQ-5D-5L population normative data," Social Science & Medicine, Elsevier, vol. 279(C).
    6. Lisa A. Prosser & Eve Wittenberg, 2019. "Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness," PharmacoEconomics, Springer, vol. 37(4), pages 447-450, April.

  2. Jamison Pike & Scott D. Grosse, 2018. "Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review," Applied Health Economics and Health Policy, Springer, vol. 16(6), pages 765-778, December.

    Cited by:

    1. Marco Hafner & Erez Yerushalmi & Fredrik L. Andersson & Teodor Burtea, 2023. "Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 654-674, March.
    2. Yashika Chugh & Radha Krishan Dhiman & Madhumita Premkumar & Shankar Prinja & Gagandeep Singh Grover & Pankaj Bahuguna, 2019. "Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal cove," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-24, August.
    3. Beata Gavurova & Miriama Tarhanicova, 2021. "Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption," IJERPH, MDPI, vol. 18(9), pages 1-25, May.
    4. Baudouin Standaert & Christophe Sauboin & Quentin J. Leclerc & Mark P. Connolly, 2021. "Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs," PharmacoEconomics, Springer, vol. 39(2), pages 257-269, February.
    5. Błażej Łyszczarz & Karolina Sowa, 2022. "Production losses due to mortality associated with modifiable health risk factors in Poland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(1), pages 33-45, February.
    6. Hanly, Paul & Ortega Ortega, Marta & Pearce, Alison & Soerjomataram, Isabelle & Sharp, Linda, 2020. "Advances in the methodological approach to friction period estimation: A European perspective," Social Science & Medicine, Elsevier, vol. 264(C).
    7. Santini, Ziggi Ivan & Thygesen, Lau Caspar & Koyanagi, Ai & Stewart-Brown, Sarah & Meilstrup, Charlotte & Nielsen, Line & Olsen, Kim Rose & Birkjær, Michael & McDaid, David & Koushede, Vibeke & Ekholm, 2022. "Economics of mental wellbeing: a prospective study estimating associated productivity costs due to sickness absence from the workplace in Denmark," LSE Research Online Documents on Economics 116690, London School of Economics and Political Science, LSE Library.
    8. Nicolas Iragorri & Claire Oliveira & Natalie Fitzgerald & Beverley Essue, 2021. "The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 19(3), pages 325-341, May.
    9. L. M. Peña-Longobardo & J. Oliva-Moreno & C. Fernández-Rodriguez, 2023. "The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(8), pages 1271-1283, November.
    10. Johan A. Liseth Hansen & Thomas Fast & Knut Reidar Wangen, 2023. "Productivity Loss Across Socioeconomic Groups Among Patients With Low Back Pain or Osteoarthritis: Estimates Using the Friction-Cost Approach in Norway," PharmacoEconomics, Springer, vol. 41(9), pages 1079-1091, September.
    11. Patel, Anita & McDaid, David, 2019. "Methods for assessing costs of gambling related harms and cost-effectiveness of interventions," LSE Research Online Documents on Economics 105220, London School of Economics and Political Science, LSE Library.
    12. Katarzyna Orlewska & Pawel Orlewski & Justyna Klusek, 2021. "Suicide among Polish Adolescents—A 20 Year Analysis," IJERPH, MDPI, vol. 18(6), pages 1-12, March.
    13. Ina Rissanen & Leena Ala-Mursula & Iiro Nerg & Marko Korhonen, 2021. "Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 531-545, June.
    14. Paul Hanly & Marta Ortega Ortega & Alison Pearce & Marianna Camargo Cancela & Isabelle Soerjomataram & Linda Sharp, 2023. "Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries," PharmacoEconomics, Springer, vol. 41(9), pages 1093-1101, September.
    15. Peter Lindgren & Sofia Löfvendahl & Gunnar Brådvik & Ola Weiland & Bengt Jönsson, 2022. "Value appropriation in hepatitis C," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 1059-1070, August.
    16. Juan Oliva-Moreno & Marta Trapero-Bertran & Luz María Peña-Longobardo, 2019. "Gender Differences in Labour Losses Associated with Smoking-Related Mortality," IJERPH, MDPI, vol. 16(19), pages 1-19, September.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Jamison Pike should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.